Oral Epithelial Cells, Candida and PMN Activation
Oral Epithelial Cells, Candida and PMN Activation
批准号:
8697320
负责人:
Anna I Dongari-Bagtzoglou
金额:
$41.23万
依托单位国家:
美国
项目类别:
财政年份:
2000
资助国家:
美国
项目状态:
已结题
起止时间:
2000-09-29 至 2019-04-30
关键词:
Animal ModelAntifungal AgentsAntimicrobial ResistanceCandidaCandida albicansCandidiasisChildClinicalCollaborationsCommunitiesComplexDefense MechanismsDevelopmentDiseaseEcologyEnvironmentEnzymesEpithelial CellsEpitheliumEsophagealEsophageal mucous membraneFunding OpportunitiesGene ExpressionGenesGlucosyltransferasesGoalsGrantHIVHost DefenseHumanImmune responseImmune systemImmunocompromised HostImmunosuppressive AgentsIn VitroIndigenousIndividualIndustrial fungicideInfectionInfection ControlInflammatoryInflammatory ResponseInjuryLesionMalignant NeoplasmsMediatingMicrobial BiofilmsModelingMolecularMorbidity - disease rateMucous MembraneMusMycosesOpportunistic InfectionsOralOral candidiasisOral cavityOral mucous membrane structureOrganismPathogenesisPathogenicityPathologyPatientsPharmaceutical PreparationsPhenotypePositioning AttributePrevention strategyProcessResearchResearch Project GrantsRoleSignal TransductionStreptococcusStreptococcus mitisStreptococcus oralisSystemTLR2 geneTLR4 geneTestingVirulenceVirulence FactorsVirulentWorkbasecandida biofilmcommensal microbesextracellularfungushigh throughput screeningin vivoinsightmembermicrobialmicrobial communitymicroorganismneonateneutrophilnoveloral bacteriaoral commensaloral streptococcioral tissueoropharyngeal thrushpathogenpreventpublic health relevanceresponsetranscription factortreatment strategy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Oral thrush, a mucosal biofilm infection, continues to afflict an unacceptably high percentage of immunocompromised individuals, particularly neonates and patients on immunosuppressive medications. Although C. albicans is the primary etiologic pathogen, the microbial ecology of this infection is complex since it contains members of the endogenous bacterial flora. Candida forms mixed biofilms with streptococci in the oral cavities of humans but the role of these biofilms during the course of mucosa-associated or invasive infections is unknown. In the proposed work C. albicans and S. oralis will be used as model organisms to study the mucosal disease-promoting interactions of the non-pathogenic oral bacterial flora with opportunistic fungi that have established virulence, such as C. albicans.
Our studies rely upon a systematic and comprehensive approach to characterize both host- and pathogen-mediated aspects of the pathogenesis of mixed opportunistic mucosal infections. We hypothesize that enhanced proinflammatory host responses and increased Candida virulence mediate a pathogenic synergy of these microorganisms in the oral and esophageal mucosa. In aim I we will characterize the influence of streptococci on the TLR2/4-mediated host response to mixed infection and test the hypothesis that the exaggerated proinflammatory and neutrophilic response to mixed Candida-streptococcal biofilms leads to increased pathology. In aim II we will examine mechanisms of mixed microbial community assembly and virulence. The role of streptococcal glucosyltransferases, major enzymes contributing to the extracellular slime that promotes biofilms, will be examined. In C. albicans we will identify the transcription factor(s) tht control dual community assembly. We will also test the hypothesis that S. oralis increases the virulence of C. albicans by modulating several Rim101-dependent virulence genes, important in oral mucosal invasion, using a mouse oral co-infection model. An understanding of the effects of oral streptococci on Candida virulence and the mucosal inflammatory response will provide important novel insights into the pathogenesis of fungal infection within the oral and esophageal host niche. More importantly, the discovery of a synergistic role for oral bacteria in pathogenesis
may have important clinical implications in the treatment of oral thrush which is currently based solely on antifungals.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Control of heterogeneous microbial communities using model-based multi-objective optimization
-
批准号:10268262
-
项目类别:
-
资助金额:$42.18万
-
财政年份:2018
-
负责人:Anna I Dongari-Bagtzoglou
-
依托单位:
Control of heterogeneous microbial communities using model-based multi-objective optimization
-
批准号:10267334
-
项目类别:
-
资助金额:$42.18万
-
财政年份:2018
-
负责人:Anna I Dongari-Bagtzoglou
-
依托单位:
Model of chemotherapy-induced mucositis
-
批准号:8871565
-
项目类别:
-
资助金额:$19.94万
-
财政年份:2014
-
负责人:Anna I Dongari-Bagtzoglou
-
依托单位:
Model of chemotherapy-induced mucositis
-
批准号:8770223
-
项目类别:
-
资助金额:$22.97万
-
财政年份:2014
-
负责人:Anna I Dongari-Bagtzoglou
-
依托单位:
Oral Epithelial Cells, Candida and PMN Activation
-
批准号:7932529
-
项目类别:
-
资助金额:$21.34万
-
财政年份:2009
-
负责人:Anna I Dongari-Bagtzoglou
-
依托单位:
ORAL INFECTION AND INFLAMMATION IN TRANSPLANT PATIENTS
-
批准号:7719123
-
项目类别:
-
资助金额:$0.79万
-
财政年份:2008
-
负责人:Anna I Dongari-Bagtzoglou
-
依托单位:
ORAL CANDIDA
-
批准号:7719112
-
项目类别:
-
资助金额:$0.83万
-
财政年份:2008
-
负责人:Anna I Dongari-Bagtzoglou
-
依托单位:
ORAL INFECTION AND INFLAMMATION IN TRANSPLANT PATIENTS
-
批准号:7607625
-
项目类别:
-
资助金额:$2.83万
-
财政年份:2007
-
负责人:Anna I Dongari-Bagtzoglou
-
依托单位:
ORAL CANDIDA
-
批准号:7607610
-
项目类别:
-
资助金额:$0.98万
-
财政年份:2007
-
负责人:Anna I Dongari-Bagtzoglou
-
依托单位:
ORAL INFECTION AND INFLAMMATION IN TRANSPLANT PATIENTS
-
批准号:7377365
-
项目类别:
-
资助金额:$8.38万
-
财政年份:2006
-
负责人:Anna I Dongari-Bagtzoglou
-
依托单位:
ORAL INFECTION AND INFLAMMATION IN TRANSPLANT PATIENTS
-
批准号:7203965
-
项目类别:
-
资助金额:$0.08万
-
财政年份:2005
-
负责人:Anna I Dongari-Bagtzoglou
-
依托单位:
ORAL CANDIDA
-
批准号:7203940
-
项目类别:
-
资助金额:$0.12万
-
财政年份:2005
-
负责人:Anna I Dongari-Bagtzoglou
-
依托单位:
Oral infection and inflammation in transplant patients
-
批准号:6887257
-
项目类别:
-
资助金额:$21.75万
-
财政年份:2004
-
负责人:Anna I Dongari-Bagtzoglou
-
依托单位:
Oral Candida
-
批准号:6975313
-
项目类别:
-
资助金额:$0.55万
-
财政年份:2004
-
负责人:Anna I Dongari-Bagtzoglou
-
依托单位:
Oral infection and inflammation in transplant patients
-
批准号:6949093
-
项目类别:
-
资助金额:$18.13万
-
财政年份:2004
-
负责人:Anna I Dongari-Bagtzoglou
-
依托单位:
ORAL MUCOSAL CELLS, CANDIDA AND CYTOKINE PRODUCTION
-
批准号:6379848
-
项目类别:
-
资助金额:$4.26万
-
财政年份:2000
-
负责人:Anna I Dongari-Bagtzoglou
-
依托单位:
ORAL EPITHELIAL CELL CYTOKINES CANDIDA & PMN ACTIVATION
-
批准号:6524120
-
项目类别:
-
资助金额:$18.49万
-
财政年份:2000
-
负责人:Anna I Dongari-Bagtzoglou
-
依托单位:
Oral Epithelial Cells, Candida and PMN Activation
-
批准号:10668279
-
项目类别:
-
资助金额:$58.52万
-
财政年份:2000
-
负责人:Anna I Dongari-Bagtzoglou
-
依托单位:
Oral Epithelial Cells, Candida and PMN Activation
-
批准号:10451819
-
项目类别:
-
资助金额:$56.47万
-
财政年份:2000
-
负责人:Anna I Dongari-Bagtzoglou
-
依托单位:
ORAL EPITHELIAL CELL CYTOKINES CANDIDA & PMN ACTIVATION
-
批准号:6380022
-
项目类别:
-
资助金额:$21.74万
-
财政年份:2000
-
负责人:Anna I Dongari-Bagtzoglou
-
依托单位:
海外基金